External closing date is 19 May 2008; UNE internal closing date is 16 May 2008.
dhoba@doh.health.nsw.gov.au
The NSW Health Drug and Alcohol Research Grants Program is administered through the Mental Health and Drug & Alcohol Office (MHDAO). Each year a number of research grants are allocated to contribute towards well informed clinical practice in drug and alcohol services and programs in NSW. This grants program helps MHDAO fulfil its responsibility under the Drug Summit funding, NSW Health Drug and Alcohol Plan and drug and alcohol issues across the state.
CRITERIA
Round 1:
1. The research must be based on NSW populations, and an investigator or industry partner must be based in NSW.
2. Applicants must clearly state under which ‘category’ their application is to be assessed. The Research Sub Committee has established the following four priorities (categories) for 2008/09:
1. Workforce
a. Evaluation of innovative modality of service delivery and treatment (Information Technology, on-line, telephone, video-link, nurse practitioner etc.)
b. Clinician fatigue, burnout and trauma (incidence, severity, stress and/or resilience factors)
c. Evaluation of NSW/National guidelines/policy implementation
2. Alcohol Interventions
a. Pharmacotherapies (maintenance and withdrawal)
b. Harm reduction
c. Special populations (e.g. pregnant women, Aboriginal, liver disease, adolescents and older persons etc.)
3. Psychostimulants (evaluation, withdrawal, mental health)
4. Other Clinical Programs
a. Investigators are also invited to submit applications for research into other clinical programs (Opioid Treatment Program, Hepatitis C Virus, clinical drug and alcohol research etc.)
3. Applicants must clearly indicate which ‘type’ of grant they are applying for; there are two types of applications in 2008/09. These are:
i. Clinician Conducted Research Grant (CCRG) - encourages clinicians to conduct research in their clinical setting. CCRG applications that have demonstrated support (financial and/or flexible working time) will be strongly regarded. For examples of CCRG projects, refer to Appendix 1. CCRG applications must be aimed at one of the four priority areas. Applicants should have links to a research team, or be supervised by an experienced researcher, or be able to demonstrate capacity in research methodology. These grants will be awarded in the range of $5,000 to $15,000.
ii. Research Grant (RG) – invites applicants to conduct a research study in one of the four priority areas. These grants will normally be awarded in the range between $50,000 to $100,000. Whilst researchers from across Australia are invited to apply demonstrated links and engagement of a NSW Area Health Service will be considered in awarding RG’s.
4. CCRG applications should have demonstrated links to local services that are relevant to the research project.
5. CCRG applications will be assessed on different criteria to the RG applications, the CCRG criteria includes:
a. Past experience of applicant
b. Supervisor experience
c. Importance of the potential findings and outcomes
d. Need for funding into the area proposed
e. Scientific validity of the project
f. Method
g. Feasibility of the proposal
h. Track record of applicant
i. Likelihood of publication
j. Application to clinical practice
6. RG applications are assessed on the following criteria:
a. Potential to provide significant advance and/or important discovery and/or innovation to field
b. Potential to provide an answer to an important question
c. Relevance in clinical practice and policy, applicability across system
d. Appropriateness and quality of methods and timeline proposed
e. Feasibility of recruitment
f. Demonstrated skills to conduct the research
g. Availability of resources
7. Applications must adhere to the page limit indicated on the template and also address all specified areas listed.
8. Applications must be endorsed by the Area Drug and Alcohol Director and/or Chief Executive (CE) or their nominee, in writing.
General Information:
• Consideration will be given to funding preliminary work that will contribute to future applications to other funding bodies. This grant may also be used for pilot studies to support future submissions for a larger research study.
• Tobacco-based research projects will be not be eligible for funding through the program, with the exception of research that investigates the relationship between tobacco and alcohol and illicit drugs.
• Successful applicants are required to submit a six month and final report. Non-submission of a report will result in the researcher being viewed unfavourably in any future applications to the NSW Health Drug and Alcohol Research Grants Program.
• A grant’s duration is generally one year.
• There is no set amount on the funding specified for each priority area.
• A total amount of approximately $400,000 will be awarded in 2008/09.
• In certain circumstances continued funding may be considered upon the conclusion of a recipient’s 1-year grant.
Continued funding will be contingent on the following conditions:
o Applications will be submitted and assessed competitively alongside all other applications.
o Continued funding through the MHDAO.
o That satisfactory progress has been made at the end of the first year of funding.
o That a second year of funding builds on the first year’s findings.
o Project demonstrates potential for publication and dissemination of findings.